Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katja Gall"'
Autor:
Uwe Thiel, Sebastian J. Schober, Ingo Einspieler, Andreas Kirschner, Melanie Thiede, David Schirmer, Katja Gall, Franziska Blaeschke, Oxana Schmidt, Susanne Jabar, Andreas Ranft, Rebeca Alba Rubío, Uta Dirksen, Thomas G. P. Grunewald, Poul H. Sorensen, Günther H. S. Richter, Irene Teichert von Lüttichau, Dirk H. Busch, Stefan E. G. Burdach
Publikováno v:
OncoImmunology, Vol 6, Iss 5 (2017)
Background: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). Refractory ES carries a dismal prognosis and patients with bone marrow (BM) metastases do not survive irrespective of therapy. We assessed HLA-A*02:01/CHM1-specific allore
Externí odkaz:
https://doaj.org/article/3cc9a9d7f65440adbaafa92d0d5289d0
Autor:
Stefan Burdach, I. Kazantsev, Andreas Ranft, Katja Gall, Susanne Jabar, A. Prete, Angela Wawer, Sebastian J. Schober, Michael Merker, Uta Dirksen, Hendrik Gassmann, I. von Lüttichau, Peter Bader, Peter Lang, Uwe Thiel, E. Koscielniak, T Klingebiel, B. Gruhn, B. Afanasyev, Rupert Handgretinger, Miguel Angel Diaz, Heribert Jürgens, Marek Ussowicz
Publikováno v:
Bone Marrow Transplantation
Patients with advanced Ewing sarcoma (AES) carry a poor prognosis. Retrospectively, we analyzed 66 AES patients treated with allogeneic stem cell transplantation (allo-SCT) receiving HLA-mismatched (group A, n = 39) versus HLA-matched grafts (group B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1f6bbbb1f1de5db61ecb0fb2eb21e2
https://mediatum.ub.tum.de/doc/1704376/document.pdf
https://mediatum.ub.tum.de/doc/1704376/document.pdf
Autor:
Katja Gall, Alexandra Sipol, Stuart Hosie, Irene Teichert-von Luettichau, Michaela Nathrath, Stefan Burdach, Rüdiger von Eisenhardt-Rothe, Carolin Knebel, Wilko Weichert, Olaf Witt, I. V. Kazantsev, Bushra Weidenbusch, Carolin Prexler, Gunther Richter, Katja Specht, Lars H. Lindner, Frigga Beitinger, Monika Guggemoos, Marie Sophie Kesper
Publikováno v:
Oncotarget
Survival rates of pediatric sarcoma patients stagnated during the last two decades, especially in adolescents and young adults (AYAs). Targeted therapies offer new options in refractory cases. Gene expression profiling provides a robust method to cha
Autor:
M. Alter, I. Teichert-von Lüttichau, Ulrich Mansmann, Katja Gall, S. Burdach, Uta Dirksen, Guenther H. S. Richter, Bushra Weidenbusch, Lars H. Lindner
Publikováno v:
Oncology Research and Treatment. 39:1-191
Autor:
Katja Gall, Poul H. Sorensen, Uta Dirksen, Dirk H. Busch, Susanne Jabar, Uwe Thiel, Thomas G. P. Grunewald, Franziska Blaeschke, Rebeca Alba Rubío, Andreas Kirschner, Oxana Schmidt, Sebastian J. Schober, Ingo Einspieler, Irene von Lüttichau, David Schirmer, Gunther Richter, Melanie Thiede, Stefan Burdach, Andreas Ranft
Publikováno v:
OncoImmunology, Vol 6, Iss 5 (2017)
Background: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). Refractory ES carries a dismal prognosis and patients with bone marrow (BM) metastases do not survive irrespective of therapy. We assessed HLA-A*02:01/CHM1-specific allore
Publikováno v:
Blood. 132:5422-5422
Diffuse large B-cell lymphoma (DLBCL) is a rare lymphoma type in pediatric patients with usually good prognosis. We present the difficult diagnostic procedure and the complicated course in an adolescent patient with DLBCL. Case report: The 16-year-ol
Autor:
Uwe Thiel, Katja Gall, Irene von Luettichau, Andreas Kirschner, Poul H. Sorensen, Dirk H. Busch, Oxana Schmidt, Thomas G. P. Grunewald, Ingo Einspieler, Guenther H. S. Richter, Stefan Burdach, David Schirmer, Sebastian J. Schober
Publikováno v:
Clinical Cancer Research. 24:B38-B38
Background: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). Refractory ES carries a dismal prognosis and patients with bone-marrow (BM) metastases do not survive irrespective of therapy. We assessed HLA-A*02:01/CHM1 specific allore
Autor:
Katja Gall, Steffen
Publikováno v:
Marketing ZFP. 30:161-174